SMTL ID : 9i02.1

Structure of recombinant human butyrylcholinesterase in complex with (S)-N-((1-benzylpyrrolidin-3-yl)methyl)-N-methylnaphthalene-2-sulfonamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.58 Å
Oligo State
monomer
Ligands
3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
5 x GOL: GLYCEROL(Non-functional Binders)
1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)
1 x 01: ~{N}-methyl-~{N}-[[(3~{S})-1-(phenylmethyl)pyrrolidin-3-yl]methyl]naphthalene-2-sulfonamide
1 x PPI: PROPANOIC ACID(Non-covalent)
1 x SIA: N-acetyl-alpha-neuraminic acid(Non-covalent)
4 x SO4: SULFATE ION(Non-functional Binders)
2 x CL: CHLORIDE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Kosak, U. et al., Lead Optimization of a Butyrylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease. J.Med.Chem. (2025)
Release Date
2025-07-02
Peptides
Cholinesterase: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A